Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Part of paid clinical trials in Rochester, New York.

Sponsor
University of Rochester
Study ID
NCT06262321
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Radiotherapy
  • Stage 4 NSCLC

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Prophylactic Palliative Radiotherapy — RADIATION
    Prophylactic Palliative Radiotherapy

Study Details

Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standard of care systemic therapy.

Key Dates

Start date
May 15, 2024
Status verified
Aug 2025
Primary completion
Feb 1, 2029
Completion
Feb 1, 2029

Study Design

Enrollment
48 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Prophylactic Palliative Radiotherapy
    Prophylactic Palliative Radiotherapy

Primary Outcome Measure

Freedom from symptomatic progression of irradiated thoracic target(s) [ Time Frame: 6 month, 1 year, and 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of RochesterRochesterNew York14642
Therese Smudzin

Find similar trials in Rochester, NY

By research site
University of Rochester· Rochester, NY

Related Studies